You Ask, We Analyze: Why Tilray's Stock Looks Set To Soar

On Sunday evening, Benzinga asked its followers on Twitter what stock they’re buying at the open on Monday. From the replies, Benzinga selected one ticker for technical analysis.

@kukovisuals, @JasonWe80277557, @FlatTrading and @pvvardhanreddy are buying Tilray, Inc TLRY.

On Friday, President Joe Biden announced he intends to nominate Robert Califf as the new Food and Drug Administration (FDA) commissioner. Califf, who briefly headed the FDA under the Obama administration, has previously said he prescribed a cannabinoid drug as a doctor and has acknowledged the potential medical benefits of cannabis.

The announcement coincided with a typically bullish season in the cannabis sector and last week many individual names such as the cannabis space leader Canopy Growth Corporation CGC reversed into an uptrend and broke through a key resistance level near the $15 mark.

Tilray, a Canadian-based cannabis giant, also broke up bullishly from a pattern and bust through a resistance area at the $12.54 level, which indicates a larger run north may be in the cards.

See Also: Some Cannabis Companies Are Prepping for a Possible Next Wave of Legislative Change

The Tilray Chart: On Friday, Tilray broke up bullishly from a bull flag pattern on the daily chart. The stock had created the pole of the pattern on Nov. 8 and consolidated into the flag formation between Nov. 9 and Nov. 11. For technical traders, the bull flag was confirmed when Tilray broke up from the flag on massive volume where 56.2 million shares exchanged hands over the course of the day compared to the 10-day average of 2.28 million.

Tilray also confirmed it had reversed into an uptrend on Friday by creating a higher high above the Nov. 9 high of $12.71. The most recent higher low is at the $11.40 mark and although Tilray will need to eventually print another higher low it must remain above the level to continue in the trend.

In the premarket on Monday, it appeared Tilray would gap up about 5% higher at the market open. Traders will want to watch to see if the gap is filled immediately or whether sustained big bullish volume drives it up higher. Gaps are filled about 90% of the time so it's likely Tilray will fall down to fill the gap at some point in the future.

Tilray is trading above the eight-day and 21-day exponential moving averages (EMAs), with the eight-day EMA trending above the 21-day, both of which are bullish indicators. The stock is also trading above the 50-day simple moving average, which indicates longer-term sentiment is bullish.

Want direct analysis? Find me in the BZ Pro lounge! Click here for a free trial

  • Bulls want to see big bullish volume come in and push Tilray firmly up over a resistance level at $14.16, while keeping in mind the lower gap may cause selling pressure. Above the level, there is further resistance at $16 and $18.
  • Bears want to see big bearish volume come in and drop Tilray down below the $11.40 level to negate the uptrend. The stock has support at $12.54, $11.03 and $10.16.
Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsTechnicalsTop StoriesMarketsTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...